SIGA Technologies Inc. | Key People and Executives
Phillip Louis Gomez
Chief Executive Officer & Director
Eric A. Rose
Executive Chairman
Michael C. Plansky
Independent Director
Thomas E. Constance
Independent Director
Jeffrey B. Kindler
Independent Director
James J. Antal
Independent Director
Joseph W. Marshall
Independent Director
Michael J. Bayer
Independent Director
Paul G. Savas
Independent Director
Phillip Louis Gomez
Chief Executive Officer & Director
Daniel J. Luckshire
Chief Financial Officer, Secretary & Executive VP
Dennis E. Hruby
Chief Scientific Officer & Vice President
Robin E. Abrams
Chief Administrative Officer & General Counsel
Eric A. Rose
Executive Chairman
Michael C. Plansky
Independent Director
Thomas E. Constance
Independent Director
Jeffrey B. Kindler
Independent Director
James J. Antal
Independent Director
Joseph W. Marshall
Independent Director
Michael J. Bayer
Independent Director
Paul G. Savas
Independent Director
| Address |
31 East 62nd Street
New York New York 10065
United States
|
|
Employees
|
- |
| Website |
http://www.siga.com |
| Updated |
07/08/2019 |
| SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. |
